Tang W, Ren L, Liu T, Ye Q, et al. Bevacizumab Plus mFOLFOX6 Versus mFOLFOX6 Alone as First-Line Treatment for RAS
Mutant Unresectable Colorectal Liver-Limited Metastases: The BECOME Randomized
Controlled Trial. J Clin Oncol 2020;38:3175-3184.
PMID: 32749938